January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
Based on market forecasts, the spinal cord injury treatment sector will expand from USD 7.47 billion in 2024 to USD 11.94 billion by 2034, experiencing a CAGR of 4.8%. In 2023, complete spinal cord injuries led the market with a 60% share, while corticosteroids held 40%. Hospitals were the top providers, also with 60% market share. Key players in t...
April 21, 2026
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing excessive nerve signaling, preventing sudden electrical bursts that cause seizures. These medications...
April 21, 2026
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophrenia and bipolar disorder. They work by balancing brain chemicals to reduce hallucinations, delusions, ...
April 21, 2026
According to forecasts, the global musculoskeletal disorders treatment market will grow from USD 197.18 billion in 2024 to USD 353.12 billion by 2034, with an expected CAGR of 6%. Musculoskeletal disorder treatment includes pain relief, physical therapy, medications, and lifestyle changes to improve movement and function. In severe cases, surgery m...
April 21, 2026
Based on market forecasts, the inflammatory bowel disease treatment sector will expand from USD 21.01 billion in 2024 to USD 35.88 billion by 2034, experiencing a CAGR of 5.5%. The Inflammatory Bowel Disease (IBD) treatment market focuses on medications, biologics, and therapies for conditions like Crohn’s disease and ulcerative colitis. Grow...
April 21, 2026
Based on market forecasts, the global ventricular assist device market, projected at USD 1.7 billion in 2024, is expected to reach USD 3.38 billion by 2034, growing at a CAGR of 7.1% over the forecast period. The market is growing due to rising heart failure cases and advancements in medical technology. VADs help pump blood for patients with weaken...
April 21, 2026
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous efforts taken by governments and key stakeholders drive the market's growth....
April 21, 2026
Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC is driving the growth of the market....
April 21, 2026
According to market projections, the global chronic lower back pain market, valued at USD 2.69 billion in 2024, is anticipated to reach USD 6.69 billion by 2034, growing at a CAGR of 9.52% over the next decade. The increasing geriatric population with arthritis is one of the leading causes of chronic lower back pain, which is driving the market&rsq...
April 21, 2026
Based on market forecasts, the catheter related bloodstream infection sector will expand from USD 1.61 billion in 2024 to USD 2.65 billion by 2034, experiencing a CAGR of 5.13%. The increasing geriatric population and chronic conditions are driving the growth of the market....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
